Report Summary
Eternity Insights has published a new study on Global Mobile Continuous Glucose Monitoring System Market focusing on key segments as by Type (Invasive, Non-invasive (Exfoliation), Other), by Application (Self/Home Care, Hospital & Clinics, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Mobile Continuous Glucose Monitoring System Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Mobile Continuous Glucose Monitoring System Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Mobile Continuous Glucose Monitoring System Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Mobile Continuous Glucose Monitoring System Market Segmentation:
Mobile Continuous Glucose Monitoring System Market, By Type
- Invasive
- Non-invasive (Exfoliation)
- Other
Mobile Continuous Glucose Monitoring System Market, By Application
- Self/Home Care
- Hospital & Clinics
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Mobile Continuous Glucose Monitoring System market in terms of demand generation. The Mobile Continuous Glucose Monitoring System market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Mobile Continuous Glucose Monitoring System market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Mobile Continuous Glucose Monitoring System Market Taxonomy:
To learn more about this report
Global Mobile Continuous Glucose Monitoring System Market Competitive Landscape
The global Mobile Continuous Glucose Monitoring System market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Dexcom
- Medtronic
- LifeScan
- Roche
- Insulet
- Abbott Laboratories
- Panasonic Healthcare
- Echo Therapeutics
- Tandem Diabetes Care
- GlySens
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Invasive, Non-invasive (Exfoliation), Other |
| By Application Outlook |
Self/Home Care, Hospital & Clinics, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Dexcom, Medtronic, LifeScan, Roche, Insulet, Abbott Laboratories, Panasonic Healthcare, Echo Therapeutics, Tandem Diabetes Care, GlySens |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Mobile Continuous Glucose Monitoring System Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Mobile Continuous Glucose Monitoring System Market Size Growth Rate by Product
1.4.2 Invasive
1.4.3 Non-invasive (Exfoliation)
1.5 Market by End User
1.5.1 Global Mobile Continuous Glucose Monitoring System Market Size Growth Rate by End User
1.5.2 Self/Home Care
1.5.3 Hospital & Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Mobile Continuous Glucose Monitoring System Market Size
2.1.1 Global Mobile Continuous Glucose Monitoring System Revenue 2017-2027
2.1.2 Global Mobile Continuous Glucose Monitoring System Sales 2017-2027
2.2 Mobile Continuous Glucose Monitoring System Growth Rate by Regions
2.2.1 Global Mobile Continuous Glucose Monitoring System Sales by Regions
2.2.2 Global Mobile Continuous Glucose Monitoring System Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Mobile Continuous Glucose Monitoring System Sales by Manufacturers
3.1.1 Mobile Continuous Glucose Monitoring System Sales by Manufacturers
3.1.2 Mobile Continuous Glucose Monitoring System Sales Market Share by Manufacturers
3.1.3 Global Mobile Continuous Glucose Monitoring System Market Concentration Ratio (CR5 and HHI)
3.2 Mobile Continuous Glucose Monitoring System Revenue by Manufacturers
3.2.1 Mobile Continuous Glucose Monitoring System Revenue by Manufacturers (2017-2020)
3.2.2 Mobile Continuous Glucose Monitoring System Revenue Share by Manufacturers (2017-2020)
3.3 Mobile Continuous Glucose Monitoring System Price by Manufacturers
3.4 Mobile Continuous Glucose Monitoring System Manufacturing Base Distribution, Product Types
3.4.1 Mobile Continuous Glucose Monitoring System Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mobile Continuous Glucose Monitoring System Product Type
3.4.3 Date of International Manufacturers Enter into Mobile Continuous Glucose Monitoring System Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Mobile Continuous Glucose Monitoring System Sales by Product
4.2 Global Mobile Continuous Glucose Monitoring System Revenue by Product
4.3 Mobile Continuous Glucose Monitoring System Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Mobile Continuous Glucose Monitoring System Breakdown Data by End User
6 North America
6.1 North America Mobile Continuous Glucose Monitoring System by Countries
6.1.1 North America Mobile Continuous Glucose Monitoring System Sales by Countries
6.1.2 North America Mobile Continuous Glucose Monitoring System Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Mobile Continuous Glucose Monitoring System by Product
6.3 North America Mobile Continuous Glucose Monitoring System by End User
7 Europe
7.1 Europe Mobile Continuous Glucose Monitoring System by Countries
7.1.1 Europe Mobile Continuous Glucose Monitoring System Sales by Countries
7.1.2 Europe Mobile Continuous Glucose Monitoring System Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mobile Continuous Glucose Monitoring System by Product
7.3 Europe Mobile Continuous Glucose Monitoring System by End User
8 Asia Pacific
8.1 Asia Pacific Mobile Continuous Glucose Monitoring System by Countries
8.1.1 Asia Pacific Mobile Continuous Glucose Monitoring System Sales by Countries
8.1.2 Asia Pacific Mobile Continuous Glucose Monitoring System Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Mobile Continuous Glucose Monitoring System by Product
8.3 Asia Pacific Mobile Continuous Glucose Monitoring System by End User
9 Central & South America
9.1 Central & South America Mobile Continuous Glucose Monitoring System by Countries
9.1.1 Central & South America Mobile Continuous Glucose Monitoring System Sales by Countries
9.1.2 Central & South America Mobile Continuous Glucose Monitoring System Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Mobile Continuous Glucose Monitoring System by Product
9.3 Central & South America Mobile Continuous Glucose Monitoring System by End User
10 Middle East and Africa
10.1 Middle East and Africa Mobile Continuous Glucose Monitoring System by Countries
10.1.1 Middle East and Africa Mobile Continuous Glucose Monitoring System Sales by Countries
10.1.2 Middle East and Africa Mobile Continuous Glucose Monitoring System Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Mobile Continuous Glucose Monitoring System by Product
10.3 Middle East and Africa Mobile Continuous Glucose Monitoring System by End User
11 Company Profiles
11.1 Dexcom
11.1.1 Dexcom Company Details
11.1.2 Company Business Overview
11.1.3 Dexcom Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Dexcom Mobile Continuous Glucose Monitoring System Products Offered
11.1.5 Dexcom Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Company Business Overview
11.2.3 Medtronic Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Medtronic Mobile Continuous Glucose Monitoring System Products Offered
11.2.5 Medtronic Recent Development
11.3 LifeScan
11.3.1 LifeScan Company Details
11.3.2 Company Business Overview
11.3.3 LifeScan Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.3.4 LifeScan Mobile Continuous Glucose Monitoring System Products Offered
11.3.5 LifeScan Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Company Business Overview
11.4.3 Roche Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Roche Mobile Continuous Glucose Monitoring System Products Offered
11.4.5 Roche Recent Development
11.5 Insulet
11.5.1 Insulet Company Details
11.5.2 Company Business Overview
11.5.3 Insulet Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Insulet Mobile Continuous Glucose Monitoring System Products Offered
11.5.5 Insulet Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Company Business Overview
11.6.3 Abbott Laboratories Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Abbott Laboratories Mobile Continuous Glucose Monitoring System Products Offered
11.6.5 Abbott Laboratories Recent Development
11.7 Panasonic Healthcare
11.7.1 Panasonic Healthcare Company Details
11.7.2 Company Business Overview
11.7.3 Panasonic Healthcare Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Panasonic Healthcare Mobile Continuous Glucose Monitoring System Products Offered
11.7.5 Panasonic Healthcare Recent Development
11.8 Echo Therapeutics
11.8.1 Echo Therapeutics Company Details
11.8.2 Company Business Overview
11.8.3 Echo Therapeutics Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Echo Therapeutics Mobile Continuous Glucose Monitoring System Products Offered
11.8.5 Echo Therapeutics Recent Development
11.9 Tandem Diabetes Care
11.9.1 Tandem Diabetes Care Company Details
11.9.2 Company Business Overview
11.9.3 Tandem Diabetes Care Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Tandem Diabetes Care Mobile Continuous Glucose Monitoring System Products Offered
11.9.5 Tandem Diabetes Care Recent Development
11.10 GlySens
11.10.1 GlySens Company Details
11.10.2 Company Business Overview
11.10.3 GlySens Mobile Continuous Glucose Monitoring System Sales, Revenue and Gross Margin (2017-2020)
11.10.4 GlySens Mobile Continuous Glucose Monitoring System Products Offered
11.10.5 GlySens Recent Development
12 Future Forecast
12.1 Mobile Continuous Glucose Monitoring System Market Forecast by Regions
12.1.1 Global Mobile Continuous Glucose Monitoring System Sales Forecast by Regions 2019-2025
12.1.2 Global Mobile Continuous Glucose Monitoring System Revenue Forecast by Regions 2019-2025
12.2 Mobile Continuous Glucose Monitoring System Market Forecast by Product
12.2.1 Global Mobile Continuous Glucose Monitoring System Sales Forecast by Product 2019-2025
12.2.2 Global Mobile Continuous Glucose Monitoring System Revenue Forecast by Product 2019-2025
12.3 Mobile Continuous Glucose Monitoring System Market Forecast by End User
12.4 North America Mobile Continuous Glucose Monitoring System Forecast
12.5 Europe Mobile Continuous Glucose Monitoring System Forecast
12.6 Asia Pacific Mobile Continuous Glucose Monitoring System Forecast
12.7 Central & South America Mobile Continuous Glucose Monitoring System Forecast
12.8 Middle East and Africa Mobile Continuous Glucose Monitoring System Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mobile Continuous Glucose Monitoring System Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
